Evidence map›Paper›PMID 39451414›Full record

ArticleBioengineering (Basel, Switzerland)2024

Enhancing Cardiovascular Risk Prediction: Development of an Advanced Xgboost Model with Hospital-Level Random Effects.

Tim Dong, Iyabosola Busola Oronti, Shubhra Sinha, Alberto Freitas, Bing Zhai, Jeremy Chan, Daniel P Fudulu, Massimo Caputo, Gianni D Angelini

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tim DongBristol Heart Institute, Translational Health Sciences, University of Bristol, Bristol BS2 8HW, UK.ORCID 0000-0003-1953-0063
Iyabosola Busola OrontiStatistics and Risk Unit (AS&RU), Department of Statistics, School of Engineering, University of Warwick, Coventry CV4 7AL, UK.ORCID 0000-0001-5324-6408
Shubhra SinhaBristol Heart Institute, Translational Health Sciences, University of Bristol, Bristol BS2 8HW, UK.
Alberto FreitasFaculty of Medicine, University of Porto, 4200-319 Porto, Portugal.ORCID 0000-0003-2113-9653
Bing ZhaiSchool of Computing Science, Northumbria University, Newcastle upon Tyne NE1 8ST, UK.
Jeremy ChanBristol Heart Institute, Translational Health Sciences, University of Bristol, Bristol BS2 8HW, UK.ORCID 0000-0002-3009-5712
Daniel P FuduluBristol Heart Institute, Translational Health Sciences, University of Bristol, Bristol BS2 8HW, UK.
Massimo CaputoBristol Heart Institute, Translational Health Sciences, University of Bristol, Bristol BS2 8HW, UK.
Gianni D AngeliniBristol Heart Institute, Translational Health Sciences, University of Bristol, Bristol BS2 8HW, UK.

Funding

British Heart Foundation CH/17/1/32804
6 · The paper itself

Abstract

backgroundEnsemble tree-based models such as Xgboost are highly prognostic in cardiovascular medicine, as measured by the Clinical Effectiveness Metric (CEM). However, their ability to handle correlated data, such as hospital-level effects, is limited.

objectivesThe aim of this work is to develop a binary-outcome mixed-effects Xgboost (BME) model that integrates random effects at the hospital level. To ascertain how well the model handles correlated data in cardiovascular outcomes, we aim to assess its performance and compare it to fixed-effects Xgboost and traditional logistic regression models.

methodsA total of 227,087 patients over 17 years of age, undergoing cardiac surgery from 42 UK hospitals between 1 January 2012 and 31 March 2019, were included. The dataset was split into two cohorts: training/validation (n = 157,196; 2012-2016) and holdout (n = 69,891; 2017-2019). The outcome variable was 30-day mortality with hospitals considered as the clustering variable. The logistic regression, mixed-effects logistic regression, Xgboost and binary-outcome mixed-effects Xgboost (BME) were fitted to both standardized and unstandardized datasets across a range of sample sizes and the estimated prediction power metrics were compared to identify the best approach.

resultsThe exploratory study found high variability in hospital-related mortality across datasets, which supported the adoption of the mixed-effects models. Unstandardized Xgboost BME demonstrated marked improvements in prediction power over the Xgboost model at small sample size ranges, but performance differences decreased as dataset sizes increased. Generalized linear models (glms) and generalized linear mixed-effects models (glmers) followed similar results, with the Xgboost models also excelling at greater sample sizes.

conclusionsThese findings suggest that integrating mixed effects into machine learning models can enhance their performance on datasets where the sample size is small.

Indexed as

AIcardiovascular medicineexpectation–maximizationmachine learningrandom effectsrisk predictionxgboost

Identifiers

PMID39451414
PMCPMC11505330

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.